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Abstract
Background While the methods for conducting health economics research in general are improving, current guidelines 
provide limited guidance regarding resource use measurement (RUM). Consequently, a variety of methods exists, yet there 
is no overview of aspects to consider when deciding on the most appropriate RUM methodology. Therefore, this study aims 
to (1) identify and categorize existing knowledge regarding aspects of RUM, and (2) develop a framework that provides a 
comprehensive overview of methodological aspects regarding RUM.
Methods Relevant articles were identified by enrolling a search string in six databases and handsearching the DIRUM data-
base. Included articles were descriptively reviewed and served as input for a comprehensive framework. Health economics 
experts were involved during the process to establish the framework’s face validity.
Results Forty articles were included in the scoping review. The RUM framework consists of four methodological RUM 
domains: ‘Whom to measure’, addressing whom to ask and whom to measure; ‘How to measure’, addressing the different 
approaches of measurement; ‘How often to measure’, addressing recall period and measurement patterns; and ‘Additional 
considerations’, which covers additional aspects that are essential for further refining the methodologies for measurement. 
Evidence retrieved from the scoping review was categorized according to these domains.
Conclusion This study clustered the aspects of RUM methodology in health economics into a comprehensive framework. 
The results may guide health economists in their decision making regarding the selection of appropriate RUM methods 
and developing instruments for RUM. Furthermore, policy makers may use these findings to review study results from an 
evidence-based perspective.
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1 Introduction
As healthcare needs increasingly outweigh available 
resources, policy makers are more commonly using eco-
nomic evaluations to guide efficient resource allocation [1]. 
As part of such evaluations, the total costs associated with 
an intervention are calculated by multiplying resource use 
measurement (RUM) estimates (e.g. the number of general 
practitioner visits) by the corresponding unit prices (e.g. €33 
per visit) [2]. Accordingly, measuring the true quantities of 
the resources utilized is a vital part of generating valid cost-
ing estimates [3, 4]. In economic evaluations conducted from 
a societal perspective, i.e. when all relevant costs and ben-
efits are accounted for regardless of where they occur, RUM 
covers a broad spectrum of services in the healthcare sector 
(e.g. general practitioner visits) as well as in other sectors 
[5]. These may include sectors such as the social care sector 
(e.g. home carer visits), the education sector (e.g. special 
education services), and the criminal justice sector (e.g. con-
tacts with the police) [6]. In addition to services, time and 
money are also considered resources; therefore productivity 
losses, time spent providing informal care, and out-of-pocket 
expenses associated with one’s health may also be covered 
in RUM. The variety of resources to be measured in health 
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Key Points for Decision Makers 
Resource use measurement (RUM) is often based on 
practicality rather than on evidence-based methodolo-
gies. This could result in inaccurate results of health 
economic studies and could inherently misinform policy 
decision makers. While some methodological studies 
have focused on specific aspects of RUM, a general over-
view that constitutes RUM as a whole is lacking.
This study provides a framework of RUM aspects and 
domains, including the current recommendations based 
on literature review and expert input. This could help 
health economics researchers select the best suitable 
measurement approach for their study and thus improve 
the chances to obtain accurate outcomes.
RUM is complex and combining existing recommenda-
tions that focused on one aspect generated new insights. 
In addition, it exposes the research gap of where meth-
odological evidence is lacking most and future meth-
odological research could focus on. It stimulates further 
research to use evidence-based RUM approaches, thus 
providing improved evidence for policy decision making.
on the appropriate methods for RUM remain scarce as the 
existing guidelines focus predominantly on resource use val-
uation and outcome measurement [3, 10, 11]. A review on 
current methodological guidelines in 33 countries addressed 
only the types of costs that could be relevant for inclusion 
in economic evaluations, but did not provide guidance on 
how to appropriately measure those [12]. Current health 
technology assessment (HTA) guidelines worldwide (e.g. in 
the US, the UK, Australia and The Netherlands [2, 13–15]) 
lack information on adequate measurement of resources. 
Its current focus is predominantly on cost valuation and on 
quality-of-life measurement, but fails to provide concrete 
guidance for health economists on RUM aspects, i.e. how 
to obtain resource use data, how to define the most optimal 
recall period, or how to select the most appropriate RUM 
instrument, among others. Consequently, a wide variety of 
measurement methods exist and the choice of a measurement 
method often relies on practicality rather than on evidence 
[3], for example when a convenient recall period is chosen, 
rather than investigating which recall period leads to the 
most valid resource use estimates. Existing RUM instru-
ments lack transparency in their development process; thus, 
it remains unclear which decisions were made with regard 
to their RUM approach [9]. This can affect the methodo-
logical quality of an economic evaluation and compromise 
the likelihood of acquiring accurate cost estimates [16]. 
Furthermore, the variability in national RUM guidelines on 
the recommended perspective [8] increases the variability 
of costing research, which compromises its comparability. 
Given that the use of different RUM methods may gener-
ate different results [17], more information is needed on the 
consequences of RUM methods.
Published methodological studies focus on specific ques-
tions related to RUM, such as, among others, ‘whom to 
ask’ or ‘do pharmaceutical data and patient-collected data 
agree?’[18, 19]. Often, the generalizability of the results is 
limited and findings may be contradictory; hence, which 
recommendations to follow remains unclear. Until now, no 
framework is available that provides an overview of RUM 
recommendations, although this could provide guidance to 
researchers regarding evidence-based decision making in 
relation to RUM methodology. Therefore, this study aims 
to (1) identify and categorize published evidence from stud-
ies regarding the methodological aspects of RUM, and (2) 
develop a framework that provides a comprehensive over-
view of these aspects of RUM in health economics research.
2  Methods
This study was conducted in three chronological phases, as 
visualized in Fig. 1.
economics research calls for a harmonized evidence-based 
approach towards RUM.
RUM is part of the bigger cost measurement process in 
health economics research [7]. The process of cost measure-
ment is often divided into a three-step process, containing 
the (1) identification of costs, (2) measurement of costs, and 
(3) valuation of costs. During the first step, identification, the 
costs that are considered relevant for inclusion for a study 
are determined. This depends on, among other factors, the 
aim of the study, the perspective, and the target audience of 
the results (e.g. policy makers, hospital managers). Recom-
mended perspectives differ per country [8] and some coun-
tries may have no national guidelines at all. Identification 
is finalized before the measurement of costs (step 2). The 
second step refers to the actual measurement of resources 
used and is referred to as RUM. The purpose of the second 
step is to quantify the total resource use in a given time span 
per individual or per population, depending on the aim of 
the study. The final step in the process is to determine the 
unit costs per unit of measurement to be able to calculate 
the total costs. These results can then be used to calculate 
the total burden of a disease or can serve as part of cost-
effectiveness analyses.
RUM, the second step of the process, is known to be a 
challenging and time-consuming, yet essential, step in eco-
nomic evaluations [3, 9]. However, literature and guidance 
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Phase 1 consisted of a workgroup meeting followed by a 
brief literature check. The purpose of the workgroup meeting 
was to brainstorm about the outline of the study. A work-
group consisting of seven health economists (LJ, SE, AP, 
CD, WH, SN, JT) brainstormed to identify existing RUM 
aspects in health economics, i.e. all concepts that are part 
of the complex phenomenon of RUM. Afterwards, the four 
methodological studies [3, 4, 20, 21] on RUM, familiar with 
the workgroup, were read full-text by one researcher (LJ) 
to validate the identified RUM aspects and to complement 
the list with other relevant RUM aspects. The RUM aspects 
identified during the expert meeting and the RUM aspects 
identified in the literature provided the input for the draft 
framework, developed in the next phase.
In Phase 2, the listed RUM aspects (that were identi-
fied in Phase 1) that seem to be connected, were clustered 
into broader domains. This clustering resulted in the draft 
framework, which was checked for validity by the PECU-
NIA consortium in a joint online meeting. This consortium 
consists of a group of health economics experts from 10 aca-
demic institutions in Europe [6]. The consortium studied the 
framework for face validity and completeness. No additional 
RUM aspects were mentioned and no other changes were 
suggested; ergo, the draft framework remained unchanged.
Thereupon, a scoping review was conducted that aimed 
to identify existing evidence-based findings and possible 
recommendations regarding the RUM aspects included 
in the framework. Scoping reviews are considered a suit-
able method to gather literature for lesser known fields, as 
their research questions are broader than those of literature 
reviews [22]. Scoping reviews aim to “map rapidly the key 
concepts underpinning a research area and the main sources 
and types of evidence available” [23]. They can be useful in 
complex areas or areas that have not yet been comprehen-
sively reviewed. Relevant literature for the scoping review 
was gathered using three approaches. First, a structured lit-
erature search was conducted. The search scopes of four 
existing systematic reviews addressing RUM that were iden-
tified by the experts in Phase 1 were used as a basis for the 
current literature search [3, 4, 20, 21]. Databases were cho-
sen based on the scope and topic coverage and, as RUM is a 
relatively new and underexplored area of research, multiple 
databases were chosen. Six electronic databases, including 
EconLIT, EMBASE (Ovid), Education Resources Informa-
tion Centre (ERIC), MEDLINE (PubMed), PsycINFO, and 
the Social Science Citation Index (SSCI; Web of Science), 
were searched in April 2018. The search strategy was devel-
oped to identify methodological papers addressing RUM 
recommendations (electronic supplementary material [ESM] 
1). All papers were screened by one researcher (LJ) and, 
based on title and abstract, categorized as included, excluded 
or undecided. The articles that were categorized as unde-
cided were screened by a second researcher (KG) and were 
included if the second researcher favoured their inclusion.
Second, the Database of Instruments for Resource Use 
Measurement (DIRUM), an open access database for 
resource use questionnaires, was hand-searched for rel-
evant methodological papers in May 2018 [24]. At the time, 
DIRUM contained 97 articles and all were hand-searched, 
i.e. all titles and abstracts were read. Third, the members of 
the PECUNIA consortium (i.e. the same health economics 
experts who validated the framework in Phase 2) were asked 
to send potentially relevant articles to the authors.
Fig. 1  Methodological phases 
(1–3) of this study
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The articles retrieved from both the structured literature 
search and the DIRUM database after title and abstract 
screening, and the articles that were recommended by the 
experts, underwent the same descriptive reviewing proce-
dure. All articles were read full-text and were included in the 
study if the eligibility criteria were fulfilled. Methodological 
papers, i.e. studies that set out to answer a methodologi-
cal question, that addressed RUM and were available in the 
English language were eligible for inclusion. The included 
articles were descriptively reviewed and the information 
regarding RUM aspects was extracted according to the data 
extraction template developed by the authors serving the 
aim of this study (ESM 2). The template was developed over 
online author meetings based on what authors believed was 
key information to be extracted. The results of the scoping 
review generated new insights and were used to update the 
framework in order to increase the mutual exclusivity of 
the aspects while balancing conciseness and completeness.
In the final phase, Phase 3, the framework was operation-
alized in multiple group discussions with the authors. Dur-
ing the operationalization process, definitions were created 
for the RUM domains and aspects to increase the usability of 
the framework for future studies. Developing definitions fur-
thermore served to increase disambiguation of aspects and 
to decrease overlap as much as possible. Additionally, this 
step served as a final check whether the authors all agreed 
on the conceptualization of the framework. The framework 
was finalized and the results of the scoping review were 
categorized within it accordingly.
3  Results
The face-to-face expert meeting and four systematic reviews 
addressing RUM [3, 4, 20, 21] provided the input for the draft 
framework. Clustering of the RUM aspects resulted in a frame-
work with six main methodological RUM domains and corre-
sponding aspects (ESM 3): (1) What to measure? (2) Whom to 
ask? (3) How to measure? (4) How often to measure? (5) How 
to ensure the validity and reliability of RUM? (6) Additional 
considerations. This version was used as the outline for the 
scoping review. Figure 2 displays the flow of studies included 
after identification and screening, in the form of a Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) chart [25]. The search initially identified 7438 
unique studies, 7393 of which were excluded after title and 
abstract screening, resulting in 45 remaining studies. Studies 
provided by the experts (n = 48) and studies identified via a 
search of DIRUM (n = 35) were added for full-text screen-
ing. Of the 117 unique studies included for full-text screening, 
74 were excluded because they either did not focus on RUM 
(n = 43), were not a methodological study (n = 33), or were 
written in a language other than English (n = 1), resulting in 
the inclusion of 40 studies that fulfilled the inclusion criteria 
(ESM 4); all were fully analyzed.
Data analysis generated new insights and led to a rear-
rangement of RUM aspects, resulting in the final framework 
(Fig. 3) that contains 4 RUM domains and 11 more specific 
RUM aspects. The RUM domain ‘How to ensure the validity 
and reliability of RUM?’ was renamed ‘psychometric quality’ 
and was merged as an aspect of RUM Domain 6 ‘Additional 
considerations’. Further changes are described in the footnote 
in the figure (ESM 3).
3.1  Resource Use Measurement (RUM) Domain 1: 
Whom to Ask
RUM Domain 1, ‘Whom to ask’, was discussed in 10 articles. 
This domain refers to the individual who consumes or uses a 
resource. Some personal characteristics (e.g. age) might influ-
ence the ability to recollect, and for some diseases (e.g. severe 
mental health illnesses), persons other than the individual him/
herself might be better at recalling resource use. Furthermore, 
capturing only the individuals’ resource use (i.e. excluding 
the resource use of relatives) may not be sufficient to obtain 
relevant societal outputs. Therefore, this domain consists of 
two aspects—whom to ask and whom to measure.
3.1.1  Whom to Ask
Studies disagree on the effect of personal characteristics on 
the accuracy of self-reported RUM. Two studies report that 
differences in sex and age do not affect the ability to accu-
rately recall [19, 26], while two other studies oppose this 
and conclude that patient characteristics such as age, health, 
and the amount of resource use may influence the likelihood 
of over- or underreporting [27, 28]. Another study added 
that educational attainment and functional ability may also 
affect the consistency of self-reports [29]. Literature seems 
to agree that if the target group includes people whose use 
of resources is high, recall problems are more likely to occur 
[27, 30, 31]. The studies also gave explanations for this phe-
nomenon: people whose use of resources is high may be 
more severely ill and their ill health may directly affect their 
ability to recollect; moreover, people whose resource use is 
high have more to remember, as they have more resources 
to recall. These explanations also link to the RUM aspect 
‘recall period’ in RUM Domain 4 ‘How often to measure?’. 
Furthermore, it may be possible that people (e.g. informal 
caregivers, parents) other than the patient him/herself are 
better at recalling resource use. Two studies report that 
parents can be good proxies for children, even though their 
recall is not perfect [30, 32]. We did not find any studies that 
oppose this finding, nor did we find any studies that recom-
mend involving other proxies.
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3.1.2  Whom to Measure
It could be argued that if economic evaluations are con-
ducted from a societal perspective, the costs and benefits 
of people other than the research participant should also 
be included, to capture the total impact of a disease. This 
would imply that the unit of analysis, i.e. whom to measure, 
is broader than the individual’s resource use alone. However, 
we did not find any recommendations regarding the appro-
priate unit of analysis in the reviewed literature.
3.2  RUM Domain 2: How to Measure
RUM Domain 2, ‘How to measure’, was discussed in 29 
articles. The domain consists of four aspects: the type of data 
used (either self-reported or administrative data), the dif-
ferent ways that self-reported resource use can be obtained 
(e.g. online versus pen and paper questionnaires, conducting 
an interview to collect resource use information, or with the 
use of props such as a resource use diary), the way questions 
and answer options are framed, and the relationship between 
RUM and missing data. The latter addresses only the prev-
alence of missing data. Dealing with missing data during 
analysis is considered outside the scope of the current study.
3.2.1  Self‑Reported or Administrative Data
The differences between self-reported and administrative 
data have been widely discussed in the literature. The level 
of agreement varies per study and depends on the type of 
resource use measured [3, 4, 17–19, 27–29, 31, 33–43]. 
One study reported that even if there is good agreement on 
resource use, this does not always lead to good agreement 
on costs [33]. For resource use items with high unit costs, 
a small difference in the frequency of using this resource 
may cause great variation in total costs and vice versa. It 
seems that in general, the preference for self-reported or 
administrative data depends on the perspective taken. Self-
reported data on resource use may be preferred when more 
cost categories are included (e.g. in a societal analysis). As 
it is impossible to retrieve data on out-of-pocket expenses 
and costs outside the healthcare sector from data on medical 
records, it may be easier to use one questionnaire to collect 
all information, instead of combining data from multiple 
sources.
3.2.2  Ways of Obtaining Self‑Reported Data
There are different measurement methods for obtaining self-
reported data, and every method comes with specific advan-
tages and disadvantages. Studies acknowledge an interaction 
between a questionnaire, a respondent and an interviewer 
[44]. On the one hand, an interview setting may provide for 
an increase in patient recall when interviewers probe patients 
[18]. On the other hand, a more anonymous setting (without 
a researcher present) may increase item response and leads 
to more accurate reporting, as the presence of an interviewer 
may cause social desirability bias, i.e. the overreporting of 
socially desirable behaviour [44]. Furthermore, the inter-
viewer could unintentionally increase task difficulty (for 
example when talking too fast), which in turn could decrease 
the efforts of the participants in formulating responses [45].
One study concluded that in general, people prefer face-
to-face interviews over telephone interviews, and electronic 
modes of administration over pen and paper modes [44]. 
However, the mode of questionnaire administration chosen 
for the study should also be suitable for the target group, 
as relying on internet-collected data alone could potentially 
underrepresent the elderly or less educated [46].
3.2.3  Framing
Resource use questionnaires assume that respondents share 
the same meaning for terms; however, cultural and social 
language differences can influence the interpretations of 
questions and answer options [32]. It is therefore neces-
sary to validate the RUM instrument and check if partic-
ipants share the same meaning of the items. In addition, 
the response-choice order may affect the results. One study 
found that, if the options are presented visually, the respond-
ent is more likely to select the first option in comparison 
with the subsequent options, while if the results are pre-
sented orally, the last option is more likely to be selected 
[44].
3.2.4  Missing Data
The mode of questionnaire administration and respondent 
characteristics may influence the likelihood of non-response. 
In terms of missing data, face-to-face administration is 
preferred over telephone or postal questionnaire adminis-
tration [44, 47]. The higher the non-response, the higher 
the chance that missing data are missing not at random but 
depending on certain patient characteristics [44]. Face-to-
face interviews have been identified as having the highest 
response rate [44]. As touched upon in Domain 2 ‘Whom 
to ask’, persons with high resource use may experience 
survey fatigue, which can only be minimized by shorten-
ing the questionnaire [48]. Several general solutions were 
mentioned to prevent missing data, including (1) sending 
reminders, (2) sponsorship by an official or respected body, 
(3) online questionnaires, (4) using an interviewer, and (5) 
using a resource use log [44, 45, 49]. Efforts to prevent miss-
ing data should be concentrated around the main cost drivers 
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[50], as missing data on these resources has the most impact 
on the study results. Researchers could also focus on a nar-
rower range of costs, to limit the patient burden. Missing 
data is thus linked to many other domains and aspects (e.g. 
‘Whom to ask’ and ‘How often to measure’).
3.3  RUM Domain 3: How Often to Measure
RUM Domain 3 ‘How often to measure’ was discussed in 10 
articles. The issue consists of two aspects: the recall period 
and the measurement pattern. The recall period encompasses 
the ideal recall period for different resources, and the meas-
urement pattern refers to the follow-up period of RUM.
3.3.1  Recall Period
The ideal recall period is dependent on several aspects. 
While some studies were able to advise an ‘ideal recall 
period’ for specific types of resource use, other studies sug-
gest that there is no general ideal recall period [26, 51–54]. 
Furthermore, the ability to recall may depend on the type 
of resource use, as evidence suggests that people have bet-
ter recall of salient episodes (such as an overnight stay in a 
hospital) than of routine visits [30, 36, 55]. The recall period 
should be long enough to cover all types of resource use; 
however, a (too) long recall period could decrease the accu-
racy of the responses [26, 28, 33]. The higher the number of 
visits an individual needs to recall, the greater the margin 
of potential variability [28]. The need to recall considerable 
resource use may lead to both underreporting (i.e. partici-
pants are more likely to forget or to be unwilling to write 
everything down) and overreporting (i.e. participants might 
not remember the exact date of a visit and therefore may 
include visits outside the recall period) [33]. This would 
favour a narrower (i.e. shorter) recall period; however, a 
recall period that is too narrow can lead to leaving out infre-
quent but expensive events, and shortening a recall period 
cannot fully prevent recall bias [53, 56].
3.3.2  Measurement Patterns
There is a general need to minimize patient burden, and 
intermittent data collection may be used to address this need. 
However, this requires inter- or extrapolation to fill in the 
gaps, and average estimates from intermittent data collection 
may reduce the different patterns of resource use (i.e. a spe-
cific type or amount of resource use in a given time span). 
This could be important for diseases with seasonal differ-
ences (e.g. influenza), or when trying to identify patterns of 
resource use. On the one hand, intermittent data collection 
would require the participants to recall resource use over a 
longer period, if the participant is asked less often and cov-
ers a longer recall period to lower the patient burden. On 
the other hand, asking less often but retaining a short time 
period and thus resulting in gaps that have to be filled by 
extrapolation would cause increased variability [57]. Ignor-
ing resource use patterns with data extrapolation may cause 
inaccurate results. To overcome most of these issues, it is 
essential that the sample size is large enough when using 
intermittent data collection [58].
In conclusion, the ‘How often to measure’ domain comes 
down to the trade-off between limiting information loss 
(because of a recall period that is too narrow), recall error 
(because of a recall period that is too long) and patient bur-
den (when measuring resource use too frequently, without 
an increase in data quality) [51, 53].
3.4  RUM Domain 4: Additional Considerations
RUM Domain 4, ‘Additional considerations’, was discussed 
in eight articles. This domain covers additional aspects 
that are essential for further refining the methodologies for 
measurement. The domain consists of three aspects: generic 
or disease-specific resource use, trial-based versus model-
based economic evaluations, and the psychometric quality 
of RUM.
3.4.1  Generic or Disease‑Specific
One study mentioned that a distinction should be made 
between general health loss or loss due to a specific disease 
[52]. Accordingly, the study suggested always asking partici-
pants whether another significant health problem other than 
the disease in the domain has had an impact on their use of 
resources. However, comorbidities and resource use that are 
an indirect consequence of one’s health increase the difficulty 
for respondents to make a clear distinction between generic 
resource use and disease-specific resource use. These indirect 
consequences may occur in the healthcare sector (physical pain 
as a consequence of mental illness) and outside the healthcare 
sector (productivity losses, costs in the education or criminal 
justice sector). Capturing all health-related resource use would 
reduce the risk of missing relevant resource use, even if the 
respondent does not recognize the relevance, whereas captur-
ing only disease-specific resource use would maximize causal 
precision and reduce the burden on respondents. We did not 
find any further recommendations.
3.4.2  Trial‑Based Versus Model‑Based Economic 
Evaluations
Economic evaluations can either be trial-based or model-
based. Trial-based evaluations can be conducted alongside ran-
domized controlled trials (RCTs). This phenomenon is called 
‘piggybacking’. Studies agree that piggyback evaluations can 
be an appropriate means for conducting economic evaluations 
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(and employing RUM) [39, 57, 59, 60] provided methodologi-
cal challenges are acknowledged. For example, when piggy-
backing, often the main RCT outcomes determine the ideal 
sample size, while the ideal sample size for economic evalua-
tion outcomes might be different [57]. No further information 
was found on RUM in model-based economic evaluations.
3.4.3  Psychometric Quality
All previously described aspects in the framework affect 
the overall quality of RUM in a study. However, it may be 
necessary to look at the measurement properties explicitly. 
Measurement properties refer to the validity and reliability 
of the resource use measurement instrument that is used for 
a study. For example, if RUM is conducted using a ques-
tionnaire, was this questionnaire validated beforehand, and 
how? Or was the questionnaire developed serving the aim 
of the study? One study reported that often only a subset of 
validated questions is used in a questionnaire; this would 
negatively influence the psychometric quality of the RUM 
instrument [4]. Nonetheless, if this is the case, it is recom-
mended to have validated questions, at least for the main cost 
drivers. Other studies suggest using multiple data collection 
methods to increase the overall data quality [46, 61].
4  Discussion
Comprehensive guidance on valid RUM is lacking as previ-
ous studies have not been able to provide a general over-
view of methodological recommendations. There is a lack 
of transparency in the development process of existing RUM 
instruments, and current guidelines provide limited guidance 
about which aspects should be accounted for, and how, when 
conducting RUM. Therefore, the aims of this study were to 
(1) identify and cluster existing knowledge regarding RUM 
aspects, and (2) develop a framework that provides a com-
prehensive overview of methodological aspects of RUM in 
economic evaluations.
4.1  Methodological Reflection
To fulfil the aims of this study, an extensive literature search 
was conducted, synthesizing a sound rationale for appropri-
ate RUM. As the clustering of available information gen-
erated new insights and showed the complexity of RUM, 
this study adds value to the existing literature, which has 
focused mostly only on addressing one RUM aspect at a 
time. Furthermore, the involvement of international health 
economic experts throughout the study phases has increased 
the validity of the framework. Nonetheless, the study was 
also prone to several limitations. As this was the first attempt 
to generate an overview of the existing evidence, no quality 
assessment was performed for the included studies. It was 
decided that gathering the existing evidence outweighs 
the need for including studies based on quality assessment 
scores. In addition, to date no acknowledged quality criteria 
regarding methodological studies exist. Furthermore, the 
search strategy of the scoping review aimed for the retrieval 
of RUM aspects in general and did not focus on specific 
RUM aspects. Nevertheless, the probability of missing rel-
evant studies is low as the approach towards identifying 
existing literature was thorough. Furthermore, even though 
experts were involved in all phases, the number of experts 
was limited and this might have affected the way that the 
RUM framework was constructed.
In addition, the results of this study revealed some chal-
lenges regarding the current status quo of RUM recom-
mendations. First, in general, methodological evidence for 
all RUM aspects is scarce; only a few studies that intended 
to address RUM from a methodological perspective could 
be identified. Second, while four RUM domains were dis-
tinguished, the included articles focused mostly on the 
RUM domain ‘How to measure’ (29 of 40 included stud-
ies addressed this issue). Other RUM domains (e.g. ‘What 
to measure’ and ‘Additional considerations’) have received 
little to no attention. Third, published results can be contra-
dictory; for example, studies disagreed on the level of reli-
ability of self-reported resource use data in comparison with 
resource use data extracted from medical records [27, 28]. 
As most studies did not specify the generalizability of their 
conclusions to different settings, nor did they recommend a 
specific approach as a gold standard, it remains difficult to 
compare the results thoroughly. These findings both high-
light the need for strong evidence-based recommendations 
in RUM and explain the lack thereof.
Although RUM methods and instruments need to be adap-
tive to contextual factors to capture context-specific resource 
use, insights from these studies can be used to increase the 
validity of RUM. The results of this study can help research-
ers to enhance methodological research on RUM develop-
ment as the results address the importance and possible con-
sequences of different RUM methods. While acknowledging 
the importance of external factors such as study design and 
national guidelines in selecting perspectives, this study adds 
value as the results facilitate more evidence-based choices 
that researchers can take into account before the start of the 
study. The results of this study can also be used to broaden 
the scope of existing national HTA guidelines to provide 
more structured guidance on the aspects that should be con-
sidered for adequate RUM in health economics research. 
In addition, existing databases such as DIRUM can use the 
framework to catalogue the existing research on each aspect 
of each RUM domain. Furthermore, the clustered informa-
tion per RUM domain helps put existing RUM methodolo-
gies in perspective. In addition to applied health economic 
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studies, the results of this study also shed light on a pos-
sible focus for future methodological studies. To decrease 
the existing knowledge gap in RUM, future studies could 
focus on one single aspect of the framework and explore its 
validity, e.g. assessing the validity of proxy responses. In 
general, both applied and methodological research is needed 
to enhance the methodological body of RUM in economic 
evaluations, and inherently for the development of concrete 
RUM guidelines. Future studies could therefore focus on the 
development of a checklist for sound RUM decision making, 
for example one comparable with the checklist for judging 
preference-based measures by Brazier et al. [62].
5  Conclusion
The input of experts and existing literature regarding RUM 
recommendations were synthesized to develop a compre-
hensive framework to address the aims of this study. Its 
development was an iterative process and multiple health 
economics experts were involved in each phase. The final 
framework contains four RUM domains, each of which is 
further subdivided into more specific aspects that ought to be 
considered when deciding on, or interpreting the methodol-
ogy of, the RUM approach. Existing methodological RUM 
findings extracted from the literature were clustered accord-
ing to the framework. The results of the scoping review show 
the complexity of RUM; it encompasses a variety of aspects, 
some of which are interlinked, indicating that the choices for 
one RUM aspect may also affect other RUM aspects. For 
example, the ideal recall period (RUM Domain 3) depends 
on, among other factors, who is completing the RUM instru-
ment (RUM Domain 1) and what resource use is asked. Con-
sequently, others might argue for a different setup of the 
framework. While acknowledging that much has yet to be 
untangled, we believe that the current version is both useful 
and accurate in identifying the distinction between different 
domains and aspects.
The current study also provides valuable information for 
policy makers. The results of this study highlight the impor-
tance of appropriate RUM methodology, as it may directly 
or indirectly affect the outcome of a health economics study. 
Policy makers may use these findings to review the reliabil-
ity of study results from a more evidence-based perspective.
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